Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile
Open accessAbstract
The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation. This phenomenon reduces many unique hepatocyte functions, limiting their use in drug disposition and toxicity assessment. The aetiology of dedifferentiation has not been well defined, and further understanding of the process would allow the development of novel strategies for sustaining the hepatocyte phenotype in culture or for improving protocols for maturation of hepatocytes generated from stem cells. We have therefore carried out the first proteomic comparison of primary human hepatocyte differentiation. Cells were cultured for 0, 24, 72 and 168 h as a monolayer in order to permit unrestricted hepatocyte dedifferentiation, so as to reveal the causative signalling pathways and factors in this process, by pathway analysis. A total of 3430 proteins were identified with a false detection rate of <1 %, of which 1117 were quantified at every time point. Increasing numbers of significantly differentially expressed proteins compared with the freshly isolated cells were observed at 24 h (40 proteins), 72 h (118 proteins) and 168 h (272 proteins) (p < 0.05). In particular, cytochromes P450 and mitochondrial proteins underwent major changes, confirmed by functional studies and investigated by pathway analysis. We report the key factors and pathways which underlie the loss of hepatic phenotype in vitro, particularly those driving the large-scale and selective remodelling of the mitochondrial and metabolic proteomes. In summary, these findings expand the current understanding of dedifferentiation should facilitate further development of simple and complex hepatic culture systems.
AI snapshot
Written from the paper’s full text.
TL;DR
This study used global iTRAQ proteomics to track primary human hepatocyte dedifferentiation over 168 h in monolayer culture, identifying an escalating and selective loss of hepatic proteins rather than a wholesale collapse of all hepatocyte functions. Donor identity dominated early proteomic clustering, while culture time drove convergence toward a dedifferentiated phenotype.
Key findings
- Across three iTRAQ runs, 3430 unique proteins were detected with FDR <1%, and 1117 were quantified at every time point; significantly differentially expressed proteins increased from 40 at 24 h to 118 at 72 h and 272 at 168 h versus freshly isolated cells (p < 0.05).
- Dedifferentiation was selective: cytochromes P450 were largely down-regulated, with CYP2A6, CYP2C8, and CYP4A11 among the top down-regulated proteins at 168 h, while some CYPs such as CYP2C18 and CYP2J2 remained unaltered; only 2 of 9 detected transporters, both influx transporters SLCO1B1 and SLCO1B3, were significantly down-regulated at 168 h (p < 0.05).
- Mitochondrial and metabolic proteomes underwent major remodeling, but oxidative phosphorylation parameters remained remarkably stable between 24 and 168 h, and PHHs showed significantly increased resistance to rotenone toxicity at 168 h in all donors.
- Hierarchical clustering showed donor source was the dominant factor over the first 72 h, with convergence toward a culture-time-dependent dedifferentiated phenotype by 168 h; pathway analysis implicated proliferative/inflammatory activation and inhibition of metabolic regulators including PPARα, insulin receptor, KLF15, and TFAM.
Methods
- Primary human hepatocytes were isolated by a 2-step collagenase method from surgical waste with consent and cultured as monolayers on collagen-I-coated plates; samples were collected at 0, 24, 72, and 168 h.
- Five donors were analyzed by iTRAQ-based quantitative proteomics across three 8-plex runs, with proteins identified by mass spectrometry and statistically analyzed using LIMMA and t test modules in R; pathway, upstream regulator, and transcription factor binding analyses used IPA, PANTHER, and Mapper2.
- Functional validation included western blotting for CYP2D6, CYP2E1, CYP1A2, and actin; LC–MS–MS metabolism assays for CYP3A4 (testosterone) and CYP2D6 (dextromethorphan); Seahorse OCR/ECAR mitochondrial and glycolytic assays; and rotenone toxicity ATP assays.
Limitations
- The paper does not include a dedicated limitations section.
- The authors state that some results may be specific to monolayer culture, which was chosen deliberately to exacerbate dedifferentiation and may not fully represent complex culture systems.
- Evident from the text: proteomic analysis used five donors, functional assays used varying donor numbers (e.g., metabolism n = 3; Seahorse and rotenone n = 5), and some ADME heatmap data were derived from n = 2 or n = 1 donors, limiting generalizability and statistical power.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
5 of 16 cited sources checked · 2 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Only approximately 40% of the variation in cell protein levels can be explained by differences in the corresponding mRNA levels.
“only ~40 % of the variation in cell protein levels can be explained by differences in the corresponding mRNA levels (Schwanhausser et al. 2011).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Schwanhausser et al. 2011 source
- Findingnone given
The study carried out the first proteomic comparison of primary human hepatocyte differentiation.
“We have therefore carried out the first proteomic comparison of primary human hepatocyte differentiation.”
Quote in the paperSubstantial claim- Rests on an assumption: The aetiology of dedifferentiation has not been well defined.
- Rests on an assumption: The exact mechanisms governing hepatocyte dedifferentiation remain incompletely understood.
- Findingown data
Many energy production-associated factors are down-regulated at 168 h, including PPARalpha, insulin receptor, KLF15 and the mitochondrial transcription factor TFAM.
“Moreover, many energy production-associated factors are down-regulated at 168 h including PPARα, insulin receptor, KLF15 and the mitochondrial transcription factor TFAM.”
Quote in the paperSubstantial claim - Findingown data
Hierarchical clustering of the entire dataset shows that the dominant factor determining how samples are related is the original source of the cells, rather than time in culture.
“Hierarchical clustering of the entire dataset shows that the dominant factor in determining how the samples are related is in fact the original source of the cells, rather than time in culture (Fig. 1c).”
Quote in the paperSubstantial claim - Findingown data
Coefficient of variance analysis identified proteins with the greatest variability across the five donors, including CYP2C9 and glutamine synthetase.
“This criterion highlights a number of proteins, including CYP2C9, which is known to vary in expression between individuals (Sistonen et al. 2009), and glutamine synthetase, which is associated with differential expression according to liver zonation (Jungermann and Kietzmann 1996).”
Quote in the paperSubstantial claim
- Findingown data
A number of key mitochondrial proteins, such as mitochondrial import receptor subunits, remained largely unchanged.
“However, a number of key mitochondrial proteins, such as mitochondrial import receptor subunits, remained largely unchanged (table S5).”
Quote in the paperSubstantial claim - Findingown data
Cytochromes P450 and mitochondrial proteins underwent major changes during dedifferentiation.
“In particular, cytochromes P450 and mitochondrial proteins underwent major changes, confirmed by functional studies and investigated by pathway analysis.”
Quote in the paperSubstantial claim - Findingown data
OMA-1, a negative regulator of mitochondrial fusion, is predicted to be down-regulated.
“Furthermore, a negative regulator of mitochondrial fusion, OMA-1, is also predicted to be down-regulated (figure S2b).”
Quote in the paperNot a substantial claim - Findingown data
At the 24 and 72 h time points, samples cluster according to donor in every case.
“This is particularly pronounced at the 24 and 72 h time points, which cluster according to donor in every case.”
Quote in the paperSubstantial claim - Findingown data
The expression of proteins with known mitochondrial associations demonstrated a general downward trend of the differentially expressed proteins with time in culture, particularly at 168 h, with superoxide dismutase II being a notable exception.
“The expression of proteins with known mitochondrial associations demonstrated a general downward trend of the DEPs (bold) with time in culture, particularly at 168 h, with superoxide dismutase II being a notable exception (Fig. 3a).”
Quote in the paperSubstantial claim - Findingown data
Increasing numbers of significantly differentially expressed proteins compared with freshly isolated cells were observed at 24 h (40 proteins), 72 h (118 proteins) and 168 h (272 proteins) (p < 0.05).
“Increasing numbers of significantly differentially expressed proteins compared with the freshly isolated cells were observed at 24 h (40 proteins), 72 h (118 proteins) and 168 h (272 proteins) (p < 0.05).”
- Also stated in: § Global proteomics reveals donor-dependent variation as a major influence on dedifferentiation · plain
“40 DEPs are seen after 24 h, 118 after 72 h and 272 after 168 h in culture (p < 0.05).”
Quote in the paperSubstantial claim - Also stated in: § Global proteomics reveals donor-dependent variation as a major influence on dedifferentiation · plain
- Findingown data
Glycolytic consumption measured by ECAR shows much greater donor-dependent variation.
“Analysis of glycolytic consumption, as measured by ECAR, shows much greater donor-dependent variation (Fig. 3b (ii))”
Quote in the paperNot a substantial claim - Findingown data
Pathway analysis of the mitochondrial proteomic dataset revealed predicted roles for AMPK signalling, which increases in significance during time in culture.
“This analysis revealed predicted roles for AMPK signalling, a master regulator of energy metabolism, which increases in significance during time in culture (Figure S2a).”
Quote in the paperNot a substantial claim - Findingown data
Several mitochondrial proteins were among the ten most stable proteins during dedifferentiation.
“These included several mitochondrial proteins within the ten most stable proteins.”
Quote in the paperNot a substantial claim - Findingown data
Differentially expressed proteins and associated pathways were found at every time point.
“Throughout the analysis, differentially expressed proteins and associated pathways were found at every time point”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingreasoning
The majority of these CYPs, with the exception of CYP4F2 and 4F3, show significant down-regulation at 168 h.
“the majority, with the exception of CYP4F2 and 4F3, show significant down-regulation at 168 h”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
FECH is highly associated with the differentially expressed ADME proteins.
“is highly associated with the differentially expressed ADME proteins.”
Quote in the paperNot a substantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
The most significantly predicted up-regulated factor at 168 h was heat shock factor 2 (HSF2).
“the most significantly predicted up-regulated factor at 168 h was heat shock factor 2 (HSF2).”
Quote in the paperNot a substantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingcitation
HNF1α, C/EBP and HNF1β were amongst the most significantly associated regulators with the loss of metabolic competence.
“HNF1α, C/EBP and HNF1β were amongst the most significantly associated regulators with the loss of metabolic competence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fraczek et al. 2013 source
- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingreasoning
There is a good correlation between mRNA at 72 h and protein at 168 h in the down-regulated CYPs.
“demonstrating a good correlation between mRNA at 72 h and protein at 168 h in the down-regulated CYPs.”
Quote in the paperSubstantial claim- Rests on an assumption: The mRNA data from Richert et al. 2006 in monolayer culture are comparable to the protein data in this study.
- Findingown data
Only 2 of the 9 detected transporters are significantly down-regulated at 168 h.
“Only 2 of the 9 detected transporters are significantly down-regulated at 168 h (p < 0.05; Fig. 4e)”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
The number of significantly differentially expressed proteins increased at each time.
“The number of significantly differentially expressed proteins increased at each time”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
Some phase III proteins, including MDR1 and MVP, demonstrate up-regulation during culture.
“some phase III proteins, including multidrug resistance protein 1 (MDR1) and major vault protein (MVP), demonstrating an up-regulation during culture.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
The top three most down-regulated proteins at 168 h are CYP2A6, CYP2C8 and CYP4A11.
“the top three most down-regulated proteins at 168 h: CYP2A6, CYP2C8 and CYP4A11.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
PHH resistance to rotenone toxicity significantly increased at 168 h in all donors regardless of background bioenergetic (OCR/ECAR) profile.
“A significant increase in PHH resistance to rotenone toxicity in all donors at 168 h regardless of background bioenergetic (OCR/ECAR) profile (Fig. 3c) was found.”
Quote in the paperSubstantial claim- Rests on an assumption: Rotenone resistance is a valid functional readout of complex I mitochondrial function in PHH.
- Findingown data
Many of the tested OCR parameters remain remarkably stable between 24 and 168 h despite large-scale changes to the mitochondrial proteome.
“Furthermore, many of the tested OCR parameters remain remarkably stable between 24 and 168 h (Fig. 3b (iii)), despite the large-scale changes to the mitochondrial proteome.”
Quote in the paperSubstantial claim - Findingreasoning
These changes lead to a reduction in many mitochondrial-associated proteins, particularly those involved in lipid and fatty acid metabolism.
“These changes lead to a reduction in many mitochondrial-associated proteins, particularly those involved in lipid and fatty acid metabolism.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
The protein expression of transporters important for drug influx and efflux in the liver is relatively stable throughout the 168-h culture.
“the protein expression of the transporters identified as being important for drug influx and efflux in the liver (Zamek-Gliszczynski et al. 2012) is relatively stable throughout the 168-h culture.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zamek-Gliszczynski et al. 2012 source
- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
The two significantly down-regulated transporters are both influx transporters, SLCO1B1 and SLCO1B3.
“these are both influx transporters (SLCO1B1 and SLCO1B3).”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
ZEB1, FOXO1 and NF-Y binding sites are almost exclusively predicted to be located upstream of the differentially expressed CYPs.
“whereas ZEB1, FOXO1 and NF-Y binding sites are almost exclusively predicted to be located upstream of the differentially expressed CYPs.”
Quote in the paperSubstantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
The majority of phase I enzymes follow a relatively linear pattern of down-regulation towards 168 h.
“The heatmap highlights the loss of metabolic competence with the majority of phase I enzymes following a relatively linear pattern of down-regulation towards 168 h.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
Oxidative phosphorylation shows remarkable stability following plating during a period of substantial phenotypic change.
“given the remarkable stability of oxidative phosphorylation following plating, during a period of substantial phenotypic change”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingcitation
The results corroborate previous reports showing the importance of HNF1α alongside HNF1β, C/EBP and FOXA1 in dedifferentiation.
“The results corroborate previous reports showing the importance of HNF1α alongside HNF1β, C/EBP and FOXA1 in dedifferentiation (Padgham et al. 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Padgham et al. 1993 source
- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
The general trend of CYP expression relative to freshly isolated PHHs is downward.
“The general trend of expression relative to freshly isolated PHHs is downward”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingcitation
All CYPs with a reported gene expression >30% at 72 h maintained protein expression >60% at 168 h.
“All CYPs with a reported gene expression >30 % at 72 h maintained protein expression >60 % at 168 h.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Richert et al. 2006 source
- Rests on an assumption: The mRNA data from Richert et al. 2006 in monolayer culture are comparable to the protein data in this study.
- Findingown data
SMARCB1 is significantly associated with the ADME proteomic profile at 168 h.
“SMARCB1 is also significantly associated with the ADME proteomic profile at 168 h.”
Quote in the paperNot a substantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
Predicted binding sites for HSF2 are highly enriched in the CYPs which were not differentially expressed.
“This analysis predicted binding sites for HSF2 to be highly enriched in the CYPs which were not differentially expressed”
Quote in the paperSubstantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
Our results strongly predict a down-regulation of SMARCB1.
“Our results strongly predict a down-regulation of SMARCB1”
Quote in the paperNot a substantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Findingown data
The majority of detected CYP proteins are maintained in expression at 24 h relative to freshly isolated cells.
“the majority of the detected CYP proteins are maintained in expression at 24 h in relation to the freshly isolated cells”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
Phase II/III enzymes appear to show greater stability.
“Phase II/III enzymes appear to show greater stability”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
Analysis of CYP450 activity using probe substrates for CYP3A and 2D6 shows a loss of functional capacity that is mostly consistent with the loss of protein recorded by iTRAQ and western immunoblotting.
“analysis of CYP450 activity using probe substrates for CYP3A and 2D6 shows a loss of functional capacity that is mostly consistent with the loss of protein recorded by iTRAQ and western immunoblotting”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
CYP2A6 is the largest discriminator between freshly isolated and 168 h cultured hepatocytes.
“here, we show CYP2A6 to be the largest discriminator between freshly isolated and 168 h cultured hepatocytes.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
FECH (ferrochelatase) is significantly down-regulated at 168 h.
“FECH (ferrochelatase), a key enzyme in the production of heme, found to be significantly down-regulated at 168 h (table S2)”
Quote in the paperNot a substantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Findingown data
No single factor could mediate all the ADME-associated proteomic changes.
“Comparisons between differentially expressed and non-differentially expressed drug-metabolising proteins revealed no single factor which could mediate all the ADME-associated proteomic changes.”
Quote in the paperSubstantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Interpretationown data
These data indicate a time point-dependent cellular response to isolation and culture.
“Taken together, these data indicate a time point-dependent cellular response to isolation and culture (figure S1).”
Quote in the paperSubstantial claim - Interpretationown data
Donor phenotypic characteristics have a greater impact on the protein dedifferentiating expression profile of hepatocytes than the length of time in culture, particularly over the first 72 h of culture.
“Thus, these data suggest that phenotypic characteristics of the donor have a greater impact on the protein dedifferentiating expression profile of the hepatocytes than does the length of time in culture, particularly over the first 72 h of culture.”
Quote in the paperSubstantial claim - Interpretationown data
The key factors and pathways underlying the loss of hepatic phenotype in vitro were identified, particularly those driving large-scale and selective remodelling of the mitochondrial and metabolic proteomes.
“We report the key factors and pathways which underlie the loss of hepatic phenotype in vitro, particularly those driving the large-scale and selective remodelling of the mitochondrial and metabolic proteomes.”
Quote in the paperSubstantial claim- Rests on an assumption: The aetiology of dedifferentiation has not been well defined.
- Rests on an assumption: The exact mechanisms governing hepatocyte dedifferentiation remain incompletely understood.
- Interpretationreasoning
The large-scale down-regulation of mitochondrial proteins represents an alteration in function between freshly isolated cells and 168 h rather than a generalised loss of mitochondrial mass between these time points.
“This indicates that the large-scale down-regulation of mitochondrial proteins represents an alteration in function between freshly isolated cells and 168 h rather than a generalised loss of mitochondrial mass between these time points.”
Quote in the paperSubstantial claim - Interpretationown data
Energy production is a fundamental cellular process affected by dedifferentiation.
“Energy production is another fundamental cellular process affected by dedifferentiation that is highlighted by this study.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationown data
The proteomic and functional data suggest a dramatic remodelling of the bioenergetic proteome during monolayer culture.
“The proteomic and functional data suggest a dramatic remodelling of the bioenergetic proteome during monolayer culture.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationreasoning
These results highlight the importance of epigenetic regulation in the dedifferentiation process.
“Taken together, these results highlight the importance of epigenetic regulation in the dedifferentiation process”
Quote in the paperSubstantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
- Interpretationown data
Despite donor variability, a conserved change in essential mitochondrial function is observed as a result of time in culture.
“Together these data suggest that, despite the variability seen between donors, a conserved change in essential mitochondrial function is observed as a result of time in culture.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Rests on an assumption: Rotenone resistance is a valid functional readout of complex I mitochondrial function in PHH.
- Interpretationreasoning
Loss of ferrochelatase expression would likely reduce the intracellular heme concentration.
“thus, its loss of expression would likely reduce the intracellular heme concentration.”
Quote in the paperSubstantial claim- Rests on an assumption: Ferrochelatase catalyses the final step of the heme production pathway.
- Rests on an assumption: CYPs are dependent on heme for function.
- Interpretationreasoning
The loss of CYPs can be mainly associated with reduced transcription.
“suggesting that the loss of CYPs can be mainly associated with reduced transcription.”
Quote in the paperSubstantial claim- Rests on an assumption: The mRNA data from Richert et al. 2006 in monolayer culture are comparable to the protein data in this study.
- Interpretationreasoning
The use of a rudimentary culture system has allowed the identification of a wide array of known and novel mechanisms through which dedifferentiation influences hepatic phenotype.
“the use of a rudimentary culture system has allowed the identification of a wide array of known and novel mechanisms through which dedifferentiation influences hepatic phenotype.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationown data
Dedifferentiation is strikingly selective.
“revealing the strikingly selective nature of dedifferentiation.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Premisecitation
Cytochrome P450s have been strongly associated with a loss of expression during culture.
“Cytochrome P450s has been strongly associated with a loss of expression during culture (Rodriguez-Antona et al. 2002)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rodriguez-Antona et al. 2002 source
- Interpretationreasoning
The variable dedifferentiation of hepatocytes demonstrated in this study is likely to have an impact on attempts to achieve consistent biological assessment of multiple chemical variables.
“the variable dedifferentiation of hepatocytes demonstrated in this study is likely to have an impact on attempts to achieve consistent biological assessment of multiple chemical variables”
Quote in the paperSubstantial claim- Rests on an assumption: The majority of toxicological endpoints are assessed within 72 h of isolation.
- Interpretationown data
These mechanisms are well conserved across donors.
“suggesting that these mechanisms are well conserved across donors.”
Quote in the paperNot a substantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationown data
The alteration in the hepatocyte metabolic profile during dedifferentiation is selective rather than wholesale.
“indicating a selective, rather than wholesale alteration, in the hepatocyte metabolic profile.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationreasoning
The strictly defined culture system promotes a specific protein expression profile.
“these data suggest that the strictly defined culture system promotes a specific protein expression profile”
Quote in the paperSubstantial claim- Rests on an assumption: The culture system's conditions are strictly defined and consistent across donors.
- Interpretationown data
There is an increasing deviation from the freshly isolated donor phenotype over time.
“suggests an increasing deviation from the freshly isolated donor phenotype.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Premisecitation
At 72 h, the mRNA of CYP1A2, 2A6, 2B6, 2C8, 2E1, 3A4, 4A11, 4F2, 4F3 and 27A1 is reported to drop to below 10% of freshly isolated PHH.
“at 72 h, the mRNA of CYP1A2, 2A6, 2B6, 2C8, 2E1, 3A4, 4A11, 4F2, 4F3 and 27A1 is reported to drop to below 10 % of freshly isolated PHH (Richert et al. 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Richert et al. 2006 source
- Interpretationown data
The observed changes in basal glycolysis suggest convergence towards a culture-dependent level of basal glycolysis.
“suggestive of a convergence towards a culture-dependent level of basal glycolysis.”
Quote in the paperSubstantial claim - Interpretationnone given
This study is the first use of global proteomics as a tool for investigating primary human hepatocyte dedifferentiation.
“In this study, we have demonstrated the first use of global proteomics as a tool for investigating primary human hepatocyte dedifferentiation”
Quote in the paperNot a substantial claim - Interpretationreasoning
Essential processes are preferentially maintained, potentially at the expense of non-survival-essential proteins/functions.
“it appears that these essential processes are preferentially maintained, potentially at the expense of non-survival-essential proteins/functions.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationreasoning
Such results emphasise the apparent trade-off between cell survival and a mature hepatic phenotype in traditional in vitro systems.
“Such results emphasise the apparent trade-off between cell survival and a mature hepatic phenotype in traditional in vitro systems.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationown data
At 24 h, the metabolic potential of PHH is mostly maintained.
“showing that at 24 h the metabolic potential of PHH is mostly maintained”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
- Interpretationreasoning
As a consequence of the variable PHH phenotype at isolation, the proteome changes required to achieve this dedifferentiated phenotype are also variable.
“as a consequence of the variable PHH phenotype at isolation, the proteome changes required to achieve this dedifferentiated phenotype are also variable.”
Quote in the paperSubstantial claim- Rests on an assumption: The culture system's conditions are strictly defined and consistent across donors.
- May combine two claims. 26
- Classified as probably not a substantial claim. 8
May combine two claims.
PremisecitationPrimary human hepatocytes undergo rapid dedifferentiation following isolation, losing many unique hepatocyte characteristics and reducing the physiological relevance of the model.
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
- Also stated in: § Introduction · plain
“following isolation, primary human hepatocytes undergo a rapid dedifferentiation process in which many unique hepatocyte characteristics are lost, reducing the physiological relevance of the model (Fraczek et al. 2013; Godoy et al. 2013).”
Quote in the paperSubstantial claim1 of 2 sources checked- Also stated in: § Introduction · plain
May combine two claims.
Interpretationown dataZonation appears to be a large influencing factor on variation during culture, as pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid beta oxidation and glutamine synthesis, all related to the portocentral axis gradient of the lobule.
“In fact, zonation appears to be a large influencing factor on variation during culture as our pathway analysis of the most variable proteins revealed significant association with ketogenesis, cholesterol biosynthesis, fatty acid β oxidation and glutamine synthesis (table S4), all of these are related to the portocentral axis gradient of the lobule (Godoy et al. 2013).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Godoy et al. 2013 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPrimary human hepatocytes are an important tool for studying human liver disease and drug-induced liver injury, and other models such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells fail to offer metabolically competent and species-relevant alternatives.
“Primary human hepatocytes (PHHs) are an important tool for studying human liver disease and drug-induced liver injury (DILI), with other models, such as rat hepatocytes, hepatic cell lines and stem cell-derived hepatocyte-like cells failing to offer metabolically competent and species-relevant alternatives (Godoy et al. 2013).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Godoy et al. 2013 source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
PremisecitationCYP2A6 has been reported to be the largest discriminant between foetal and adult hepatocytes.
“CYP2A6 has been reported to be the largest discriminant between foetal and adult hepatocytes (Rowe et al. 2013)”
Quote in the paperSubstantial claim1 of 1 sources checked- cites Rowe et al. 2013 source
The Discussion reports that CYP2A6 was 5.75-fold more abundant in adult hepatocytes than in fetal liver, and the Results (Fig. 8A) show strong detection in most adult samples but weak or absent detection in fetal samples. The paper identifies multiple proteins that discriminate the groups; it does not identify CYP2A6 as the largest discriminant. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataDedifferentiation and loss of characteristic hepatocyte morphology were confirmed by microscopy.
“Dedifferentiation and loss of characteristic hepatocyte morphology were confirmed by microscopy.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 24 h, superoxide dismutase increased and histone proteins decreased.
“Interestingly, the first noticeable effects at 24 h are an increase in stress-related mediator superoxide dismutase and a decrease in histone proteins.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMetabolic pathways display a trend of increasing significance during culture, while acute phase response signalling and ROS/NOS production are significantly affected at 24 h but not at 168 h.
“Whilst metabolic pathways display a trend of increasing significance during culture, acute phase response signalling and ROS/NOS production are significantly affected at 24 h, but not at 168 h.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA total of 3430 proteins were identified with a false detection rate of less than 1%, of which 1117 were quantified at every time point.
“A total of 3430 proteins were identified with a false detection rate of <1 %, of which 1117 were quantified at every time point.”
- Also stated in: § Global proteomics reveals donor-dependent variation as a major influence on dedifferentiation · plain
“A total of 3430 unique proteins were detected across three iTRAQ runs (table S1), with 1117 identified across all samples.”
Quote in the paperNot a substantial claim- Also stated in: § Global proteomics reveals donor-dependent variation as a major influence on dedifferentiation · plain
May combine two claims.
Findingown dataMany pathways follow a linear pattern of increasing activation or inhibition, but cell survival pathways are predicted to be activated at 72 h and not at 24 or 168 h.
“Many of the pathways follow a linear pattern of increasing activation or inhibition; however, some, such as the cell survival pathways, display different dynamics, as they are predicted to be activated at 72 h, but not at 24 or 168 h.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAt 168 h, donors 2 and 5 remain separated from the other donors, while donors 1, 3 and 4 cluster together, demonstrating convergence towards a dedifferentiated phenotype more reflective of time in culture than cell source.
“The separation from the other donors is still evident at 168 h for donors 2 and 5, although these samples do cluster away from the earlier time points, whereas by this time the other three donors (1, 3 and 4) cluster together, demonstrating a convergence towards a dedifferentiated phenotype which is more reflective of time in culture than the cell source.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUpstream regulation analysis predicts activation of proliferative and inflammatory regulators and inhibition of metabolic-associated factors.
“The results suggest an activation of proliferative and inflammatory regulators and inhibition of metabolic-associated factors.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOCR analysis demonstrated clear variation in individual bioenergetic profiles at 24 h, with the 168 h profile showing greater dependence on the 24 h profile rather than time in culture.
“The analysis demonstrated a clear variation in individual bioenergetic OCR profiles at 24 h (Fig. 3b (i)), with the 168-h profile showing greater dependence on the 24 h profile, rather than time in culture.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOver 168 h of monolayer culture, hepatocytes maintained confluency but lost typical polygonal morphology by 24 h, becoming flatter and less defined epithelial cells at 72 and 168 h.
“Figure 1a shows images of the cells taken at 24, 72 and 168 h and clearly demonstrates the maintenance of confluency and the loss of the typical hepatocyte polygonal morphology (24 h), towards a culture with flatter and less defined epithelial characteristics at 72 and 168 h.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHepatic-associated proteins are not universally down-regulated; alpha-1-antitrypsin and cytokeratins 8 and 18 are up-regulated throughout the analysis.
“Of note, hepatic-associated proteins are not universally down-regulated, as exemplified by alpha-1-antitrypsin and cytokeratins 8 and 18, which are up-regulated throughout the analysis (Table S2 and S6).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBasal glycolysis shows an increase during culture in donors with lower basal glycolysis, whereas those with higher basal levels at 24 h decrease.
“Despite this variation, a trend emerges: basal glycolysis shows an increase during culture in donors with lower basal glycolysis, whereas those with higher basal levels at 24 h decrease”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth AMPK and mitochondrial fusion pathways are associated with the bioenergetic adaptation to a monolayer culture system.
“Here we have additionally shown both AMPK and mitochondrial fusion pathways to be associated with the bioenergetic adaption to a monolayer culture system.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
May combine two claims.
Findingown dataDespite an increase in CYP3A4 protein at 168 h, no corresponding increase in CYP3A activity was detected.
“despite the increase in CYP3A4 protein at 168 h, no corresponding increase in CYP3A activity was detected”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
May combine two claims.
Findingown dataThe early stages of dedifferentiation are predominantly donor-dependent, with inter-individual variation in the starting donor phenotype maintained throughout the first 72 h of culture.
“Our analysis revealed that the early stages of dedifferentiation are predominantly donor-dependent with the inter-individual variation that exists in the starting donor phenotype being maintained throughout the first 72 h of culture.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
May combine two claims.
Findingown dataIn the proteomic data, three complex I subunits were significantly down-regulated, whereas the remaining nine detected subunits were not significantly differentially expressed.
“Further investigation of the proteomic data revealed a significant down-regulation of three complex I subunits, whereas the remaining nine detected subunits were not significantly differentially expressed.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
May combine two claims.
Findingown dataECAR measurements showed similar stability, but there was a general trend of increased glycolytic parameters, including the only significantly altered factor, glycolytic reserve.
“ECAR measurements showed similar stability; however, there was a general trend of increased glycolytic parameters, including the only significantly altered factor, namely glycolytic reserve (Fig. 3b (iv)).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPANTHER analysis revealed similar percentages of proteins in each class, with the greatest proportion of proteins associated with metabolism in all subsets.
“This analysis revealed similar percentages of proteins in each class, with the greatest proportion of proteins associated with metabolism in all subsets”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
May combine two claims.
Findingown dataTargeted analysis revealed specific transcription factors that are significantly perturbed and associated with ADME DEPs.
“Targeted analysis of the transcription factors that are associated with the ADME DEPs revealed the specific regulators, which are significantly perturbed and may cause the loss of ADME proteins during dedifferentiation (table S9).”
Quote in the paperSubstantial claim- Rests on an assumption: Predicted transcription factor binding sites are functionally relevant to CYP expression.
May combine two claims.
Interpretationown dataA subset of proteins remains relatively stable during dedifferentiation and may retain in vivo-like functionality and serve as useful normalisers for protein expression changes.
“Thus, while many proteins show conserved differential expression or high levels of inter-donor variability, a subset of proteins remains relatively stable and consequently may retain in vivo-like functionality and also serve as useful normalisers for protein expression changes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGlutamine synthetase is associated with differential expression according to liver zonation.
“glutamine synthetase, which is associated with differential expression according to liver zonation (Jungermann and Kietzmann 1996)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jungermann and Kietzmann 1996 source
May combine two claims.
Interpretationown dataUsing iTRAQ-based stable isotope labelling and pathway analysis, the key changes in the PHH proteome during dedifferentiation and the inter-donor variability were identified, including variability in donor phenotype and in the subsequent dedifferentiation profile.
“Using iTRAQ-based stable isotope labelling and pathway analysis, we have identified the key changes in the PHH proteome during dedifferentiation and the inter-donor variability, which exists not only in donor phenotype, but also in the subsequent dedifferentiation profile.”
Quote in the paperSubstantial claim- Rests on an assumption: The aetiology of dedifferentiation has not been well defined.
- Rests on an assumption: The exact mechanisms governing hepatocyte dedifferentiation remain incompletely understood.
May combine two claims.
InterpretationreasoningThe donor-dependent variation in ECAR may be attributable to the known gradient of glycolysis across the portocentral axis and is consistent with the findings regarding the most variable proteins.
“which may be attributable to the known gradient of glycolysis across the portocentral axis, and is consistent with our findings regarding the most variable proteins.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCYP2C9 is known to vary in expression between individuals.
“CYP2C9, which is known to vary in expression between individuals (Sistonen et al. 2009)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sistonen et al. 2009 source
May combine two claims.
InterpretationcitationSimple in vitro culture systems may support similar expression patterns during both hepatic dedifferentiation and differentiation, because proteins up-regulated in dedifferentiation are readily detectable in stem cell-derived hepatocyte-like cells whereas many down-regulated proteins are not.
“Interestingly, these proteins are readily detectable in hepatocyte-like cells derived from stem cells (Rambhatla et al. 2003), whereas many of the down-regulated proteins are not, demonstrating that simple in vitro culture systems may support similar expression patterns during both hepatic dedifferentiation and differentiation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rambhatla et al. 2003 source
Classified as probably not a substantial claim.
PremisecitationA global proteomic approach to phenotype rat hepatocytes can provide novel information on dedifferentiation.
“We have previously shown that the use of a global proteomic approach to phenotype rat hepatocytes can provide novel information on dedifferentiation (Rowe et al. 2010)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rowe et al. 2010 source
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningStudies of more rudimentary models that result in more pronounced dedifferentiation may provide greater insight into the partially understood and currently unknown causes of dedifferentiation.
“studies of more rudimentary models which result in more pronounced dedifferentiation may consequently provide a greater insight into the partially understood and currently unknown causes of dedifferentiation.”
Quote in the paperNot a substantial claim- Rests on an assumption: The aetiology of dedifferentiation has not been well defined.
- Rests on an assumption: The exact mechanisms governing hepatocyte dedifferentiation remain incompletely understood.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWestern blot was used to validate iTRAQ results.
“Samples collected in iTRAQ buffer were quantified by Bradford assay and assessed by western blot to validate iTRAQ results.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataDedifferentiation is not solely a change in expression of whole protein classes, but is a complex, differentially controlled and active process, in which selected pathways and functions from many classes are up- or down-regulated.
“Grouping of these data showed that dedifferentiation is not solely a change in expression of whole protein classes, but that it is a complex, differentially controlled and active process, in which selected pathways and functions from many classes are up- or down-regulated.”
Quote in the paperSubstantial claim- Rests on an assumption: The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
Classified as probably not a substantial claim.
Study design and conductnone givenOnly proteins present in all samples, identified with 95% confidence (2 or more peptides) or 99% confidence (single peptide) with a false detection rate of less than 1%, were statistically analysed.
“Following iTRAQ analysis, only proteins, which were present in all samples, identified with 95 % confidence (2 or more peptides) or 99 % confidence (single peptide) with a false detection rate (FDR) of less than 1 % were statistically analysed using R open-source software”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone giveniTRAQ results were obtained relative to each donor's fresh sample to control for inter-donor variation.
“Samples were run across three 8-plex iTRAQ runs (table S1), and results obtained relative to each donor’s fresh sample to control for inter-donor variation.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The aetiology of dedifferentiation has not been well defined.
“The aetiology of dedifferentiation has not been well defined, and further understanding of the process would allow the development of novel strategies for sustaining the hepatocyte phenotype in culture or for improving protocols for maturation of hepatocytes generated from stem cells.”
The paper relies on this without support.
The exact mechanisms governing hepatocyte dedifferentiation remain incompletely understood.
“however, the exact mechanisms which govern these changes remain incompletely understood.”
The paper relies on this without support.
The full in vivo phenotype has not yet been achieved in culture.
“Despite these continued improvements and advances towards complex culture conditions which can maintain an improved phenotype over a period of weeks, the full in vivo phenotype has not yet been achieved.”
The paper relies on this without support.
The iTRAQ proteomic quantification accurately reflects relative protein expression changes in PHH culture.
“The general trend of expression relative to freshly isolated PHHs is downward; however, the majority of the detected CYP proteins are maintained in expression at 24 h in relation to the freshly isolated cells”
The paper relies on this without support.
Rotenone resistance is a valid functional readout of complex I mitochondrial function in PHH.
“To assess the functional consequence of these changes, rotenone was used as a model of complex I mitochondrial perturbation.”
The paper relies on this without support.
Predicted transcription factor binding sites are functionally relevant to CYP expression.
“Investigation into the predicted transcription factor binding sites of differentially expressed and non-differentially expressed CYPs revealed the factors that may underlie the selectivity found in the loss of xenobiotic CYPs (Table S10).”
The paper relies on this without support.
The majority of toxicological endpoints are assessed within 72 h of isolation.
“the majority of toxicological endpoints are assessed within 72 h of isolation”
The paper relies on this without support.
Ferrochelatase catalyses the final step of the heme production pathway.
“Ferrochelatase catalyses the final step of the heme production pathway”
The paper relies on this without support.
CYPs are dependent on heme for function.
“CYPs are dependent on heme for function”
The paper relies on this without support.
The mRNA data from Richert et al. 2006 in monolayer culture are comparable to the protein data in this study.
“Comparison of the trend in the CYP and transporter proteins with previously published hepatocyte monolayer gene expression data (Richert et al. 2006) allows further investigation of the loss of metabolic competence (table S8).”
The paper relies on this without support.
The culture system's conditions are strictly defined and consistent across donors.
“Taken together, these data suggest that the strictly defined culture system promotes a specific protein expression profile”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Primary human hepatocytes rapidly dedifferentiate in 2D adhesion cultures within hours, limiting their utility to short-term experiments.
“rapid dedifferentiation of seeded primary hepatocytes within hours limits their utility to short-term experiments [ 2 , 3 ].”
From 3D microperfusion of mesoscale human microphysiological liver models improves functionality and recapitulates hepatic zonation (2023) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 2 caption reverses the activation-score threshold
MinorThe methods define Z-scores of ≥2 as activated and ≤−2 as inhibited. Figure 2 instead writes the activation threshold as "2 ≥ Z-score," which reverses the inequality; the same expression appears again for the upstream-regulator panel.
“If score 2 ≥ Z-score ≤ −2, the function is predicted to be activated or inhibited, respectively.”
“Using the IPA algorithm, functions or regulators that have a Z-score of ≥2 are predicted to be activated and ≤−2 are predicted to be inhibited.”
Cites
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458 · see citing works
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1× · see citing works
“This is exemplified by the recent results, showing that only ~40 % of the variation in cell protein levels can be explained by differences in the corresponding mRNA levels (Schwanhausser et al. 2011).”
ResultLarge-scale gene function analysis with the PANTHER classification system
Mi, H., Muruganujan, A., Casagrande, J. T., & Thomas, P. D. (2013) · Nature Protocols · doi:10.1038/nprot.2013.092 · Cited by 2,422 · see citing works
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, A., Gifford, D. K., et al. (2004) · Science · doi:10.1126/science.1089769 · Cited by 1,312 · see citing works
SWI/SNF nucleosome remodellers and cancer
Wilson, B. G., & Roberts, C. W. M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3068 · Cited by 1,286 · see citing works
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · see citing works
Self-citationZonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589 · see citing works
Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells
Rambhatla, L., Chiu, C.-P., Kundu, P., Peng, Y., & Carpenter, M. K. (2003) · Cell Transplantation · doi:10.3727/000000003783985179 · Cited by 437 · see citing works
Rodríguez-Antona, C., Donato, M. T., Boobis, A., Edwards, R. J., Watts, P. S., Castell, J. V., & Gómez-Lechón, M.-J. (2002) · Xenobiotica · doi:10.1080/00498250210128675 · Cited by 420 · see citing works
Guo, L., Dial, S., Shi, L., Branham, W., Liu, J., Fang, J.-L., Green, B., Deng, H., Kaput, J., & Ning, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035873 · Cited by 348 · see citing works
Epigenetics of Reprogramming to Induced Pluripotency
Papp, B., & Plath, K. (2013) · Cell · doi:10.1016/j.cell.2013.02.043 · Cited by 319 · see citing works
Elaut, G., Henkens, T., Papeleu, P., Snykers, S., Vinken, M., Vanhaecke, T., & Rogiers, V. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017759 · Cited by 292 · see citing works
Identification of small molecules for human hepatocyte expansion and iPS differentiation
Shan, J., Schwartz, R. E., Ross, N. T., Logan, D. J., Thomas, D., Duncan, S. A., North, T. E., Goessling, W., Carpenter, A. E., & Bhatia, S. N. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1270 · Cited by 254 · see citing works
Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing
Tostões, R. M., Leite, S. B., Serra, M., Jensen, J., Björquist, P., Carrondo, M. J. T., Brito, C., & Alves, P. M. (2011) · Hepatology · doi:10.1002/hep.24760 · Cited by 246 · see citing works
In Vitro Zonation and Toxicity in a Hepatocyte Bioreactor
Allen, J. W. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfi052 · Cited by 230 · see citing works
Godoy, P., Hengstler, J. G., Ilkavets, I., Meyer, C., Bachmann, A., Müller, A., Tuschl, G., Mueller, S. O., & Dooley, S. (2009) · Hepatology · doi:10.1002/hep.22880 · Cited by 227 · see citing works
Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
Sistonen, J., Fuselli, S., Palo, J. U., Chauhan, N., Padh, H., & Sajantila, A. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32831ebb30 · Cited by 200 · see citing works
A survey of current software for network analysis in molecular biology
Thomas, S., & Bonchev, D. (2010) · Human Genomics · doi:10.1186/1479-7364-4-5-353 · Cited by 191 · see citing works
Isolation and Culture of Primary Human Hepatocytes
LeCluyse, E. L., Alexandre, E., Hamilton, G. A., Viollon‐Abadie, C., Coon, D. J., Jolley, S. L., & Richert, L. (2004) · Humana Press eBooks · doi:10.1385/1-59259-838-2:207 · Cited by 157 · see citing works
Richert, L., Liguori, M. J., Abadie, C., Heyd, B., Mantion, G., Halkic, N., & Waring, J. F. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007708 · Cited by 136 · see citing works
Bhogal, R. H., Hodson, J. A., Bartlett, D. C., Weston, C. J., Curbishley, S. M., Shepherd, E. L., Williams, K. T., Reynolds, G. M., Newsome, P. N., Adams, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018222 · Cited by 135 · see citing works
Proteome-Wide Analyses of Human Hepatocytes During Differentiation and Dedifferentiation
Rowe, C., Gerrard, D. T., Jenkins, R., Berry, A., Durkin, K., Sundstrom, L., Goldring, C. E., Park, K. B., Kitteringham, N. R., Hanley, K. P., et al. (2013) · Hepatology · doi:10.1002/hep.26414 · Cited by 133 · see citing works
Self-citationThe MAPPER2 Database: a multi-genome catalog of putative transcription factor binding sites
Riva, A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1080 · Cited by 128 · see citing works
Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0983-3 · Cited by 119 · see citing works
The MAPPER database: a multi-genome catalog of putative transcription factor binding sites
Marinescu, V. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki103 · Cited by 112 · see citing works
Zellmer, S., Schmidt‐Heck, W., Godoy, P., Weng, H., Meyer, C., Lehmann, T. J., Sparna, T., Schormann, W., Hammad, S., Kreutz, C., et al. (2010) · Hepatology · doi:10.1002/hep.23930 · Cited by 94 · see citing works
The SWI/SNF chromatin‐remodeling complex subunit SNF5 is essential for hepatocyte differentiation
Gresh, L., Bourachot, B., Reimann, A., Guigas, B., Fiette, L., Garbay, S., Muchardt, C., Hue, L., Pontoglio, M., Yaniv, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600802 · Cited by 90 · see citing works
Highlights from the International Transporter Consortium Second Workshop
Zamek-Gliszczynski, M. J., Hoffmaster, K. A., Tweedie, D. J., Giacomini, K. M., & Hillgren, K. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.126 · Cited by 82 · see citing works
No, D. Y., Lee, S.-A., Choi, Y. Y., Park, D., Jang, J. Y., Kim, D., & Lee, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050723 · Cited by 75 · see citing works
Stem cell‐derived hepatocytes as a predictive model for drug‐induced liver injury: are we there yet?
Kia, R., Sison-Young, R. L. C., Heslop, J. A., Kitteringham, N. R., Hanley, N. A., MILLS, J. S., Park, B. K., & Goldring, C. E. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04360.x · Cited by 74 · see citing works
Self-citationPadgham, C. R. W., Boyle, C. C., Wang, X. J., Raleigh, S. M., Wright, M. C., & Paine, A. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2521 · Cited by 69 · see citing works
Darnell, M., Ulvestad, M., Ellis, E. C. S., Weidolf, L. O. G., & Andersson, T. B. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195834 · Cited by 67 · see citing works
Fu, D., Mitra, K., Sengupta, P., Jarník, M., Lippincott‐Schwartz, J., & Arias, I. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304285110 · Cited by 64 · see citing works
Jiang, Q., Yan, Z., & Feng, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602740200 · Cited by 54 · see citing works
Network Analysis of Primary Hepatocyte Dedifferentiation Using a Shotgun Proteomics Approach
Rowe, C., Goldring, C. E. P., Kitteringham, N. R., Jenkins, R. E., Lane, B. S., Sanderson, C., Elliott, V., Platt, V., Metcalfe, P., & Park, B. K. (2010) · Journal of Proteome Research · doi:10.1021/pr1001687 · Cited by 51 · see citing works
Self-citationLeppä, S., Pirkkala, L., Saarento, H., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15293 · Cited by 46 · see citing works
Yousefi, B., Darabi, M., Baradaran, B., Khaniani, M. S., Rahbani, M., Darabi, M., Fayezi, S., Mehdizadeh, A., Saliani, N., & Shaaker, M. (2012) · Europe PMC (PubMed Central) · doi:10.5681/bi.2012.019 · Cited by 40 · see citing works
Möbus, S., Yang, D., Yuan, Q., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.016 · Cited by 38 · see citing works
Kim, Y.-H., Lasher, C. D., Milford, L. M., Murali, T. M., & Rajagopalan, P. (2010) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2010.0012 · Cited by 37 · see citing works
Ripple, M. O., Kim, N.-J., & Springett, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430082 · Cited by 27 · see citing works
Naiki, T., Nagaki, M., Asano, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.102 · Cited by 21 · see citing works
Fraczek, J., Vinken, M., Tourwé, D. A., Vanhaecke, T., & Rogiers, V. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9659-8 · Cited by 15 · see citing works
The role of HNF-1alpha in controlling hepatic catalase activity.
Muppala, V., Lin, C.-S., & Lee, Y. (2000) · PubMed · Cited by 13 · see citing works
Discovering Networks of Perturbed Biological Processes in Hepatocyte Cultures
Lasher, C. D., Rajagopalan, P., & Murali, T. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015247 · Cited by 12 · see citing works
The Role of HNF-1α in Controlling Hepatic Catalase Activity
Muppala, V., Lin, C.-S., & Lee, Y. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26446-4 · Cited by 7 · see citing works
A mechanism for the loss of cytochrome P-450 in primary mouse hepatocytes
Singh, G., & Veltri, K. L. (1991) · Molecular and Cellular Biochemistry · doi:10.1007/bf00233120 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029 · see citing works
Bell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327 · see citing works
Self-citationLauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 226 · see citing works
Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074369 · Cited by 189 · see citing works
Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M. (2016) · Scientific Reports · doi:10.1038/srep35434 · Cited by 156 · see citing works
3D in vitro models of liver fibrosis
van Grunsven, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.004 · Cited by 154 · see citing works
Online oxygen monitoring using integrated inkjet-printed sensors in a liver-on-a-chip system
Moya, A., Ortega‐Ribera, M., Villalba, X. G., Sowade, E., Zea, M., Illa, X., Ramón, E., Villa, R., Gracia‐Sancho, J., & Gabriel, G. (2018) · Lab on a Chip · doi:10.1039/c8lc00456k · Cited by 146 · see citing works
Xia, Y., Carpentier, A., Cheng, X., Block, P. D., Zhao, Y., Zhang, Z., Protzer, U., & Liang, T. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.009 · Cited by 139 · see citing works
iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery
Corbett, J., & Duncan, S. A. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00265 · Cited by 139 · see citing works
Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
Ewart, L. C., Dehne, E., Fabre, K. M., Gibbs, S., Hickman, J. J., Hornberg, E., Ingelman‐Sundberg, M., Jang, K., Jones, D. R., Lauschke, V. M., et al. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 130 · see citing works
Mihajlovic, M., & Vinken, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063315 · Cited by 128 · see citing works
Liver Microphysiological Systems for Predicting and Evaluating Drug Effects
Ribeiro, A. J. S., Yang, X., Patel, V. P., Madabushi, R., & Strauss, D. G. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1458 · Cited by 109 · see citing works
Walker, P., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 93 · see citing works
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 90 · see citing works
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Niu, L., Geyer, P. E., Gupta, R., Santos, A., Meier, F., Doll, S., Albrechtsen, N. J. W., Klein, S., Ortiz, C., Uschner, F. E., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210947 · Cited by 65 · see citing works
Kenny, J. R., Ramsden, D., Buckley, D. B., Dallas, S., Fung, C. A., Mohutsky, M. A., Einolf, H. J., Chen, L., DeKeyser, J. G., Fitzgerald, M., et al. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081927 · Cited by 67 · see citing works
Liver three-dimensional cellular models for high-throughput chemical testing
Yang, S., Ooka, M., Margolis, R. J., & Xia, M. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100432 · Cited by 75 · see citing works
Blackford, S. J. I., Ng, S. S., Segal, J. M., King, A., Austin, A. L. F., Kent, D., Moore, J. C., Sheldon, M., Ilić, D., Dhawan, A. K., et al. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0084 · Cited by 61 · see citing works
Bell, C. C., Chouhan, B., Andersson, L. C., Andersson, H., Dear, J. W., Williams, D. P., & Söderberg, M. P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02682-w · Cited by 61 · see citing works
Cox, C. R., Lynch, S., Goldring, C. E., & Sharma, P. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.611913 · Cited by 57 · see citing works
Self-citationYouhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 57 · see citing works
Generation of multi-cellular human liver organoids from pluripotent stem cells
(2020) · Methods in Cell Biology · doi:10.1016/bs.mcb.2020.03.009 · Cited by 55 · see citing works
Exosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System
Ogese, M. O., Jenkins, R. E., Adair, K., Tailor, A., Meng, X., Faulkner, L., Enyindah, B. O., Schofield, A. L., Díaz-Nieto, R., Ressel, L., et al. (2019) · Hepatology · doi:10.1002/hep.30701 · Cited by 46 · see citing works
Self-citationKiamehr, M., Heiskanen, L., Laufer, T., Düsterloh, A., Kahraman, M., Käkelä, R., Laaksonen, R., & Aalto‐Setälä, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122910 · Cited by 47 · see citing works
Kamalian, L., Douglas, O., Jolly, C., Snoeys, J., Simic, D., Monshouwer, M., Williams, D. P., Park, B. K., & Chadwick, A. E. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.08.001 · Cited by 42 · see citing works
Self-citationCellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process
Dickens, D., Rädisch, S., Chiduza, G. N., Giannoudis, A., Cross, M. J., Malik, H., Schaeffeler, E., Sison-Young, R. L. C., Wilkinson, E. L., Goldring, C. E., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00547 · Cited by 39 · see citing works
Self-citationWesseler, M. F., Taebnia, N., Harrison, S., Youhanna, S., Preiss, L. C., Kemas, A. M., Vegvari, A., Mokry, J., Sullivan, G. J., Lauschke, V. M., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.09.022 · Cited by 39 · see citing works
Identification of the Secreted Proteins Originated from Primary Human Hepatocytes and HepG2 Cells
Frankó, A., Hartwig, S., Kotzka, J., Ruoß, M., Nussler, A. K., Königsrainer, A., Häring, H., Lehr, S., & Peter, A. (2019) · Nutrients · doi:10.3390/nu11081795 · Cited by 38 · see citing works
Squaramide‐Based Supramolecular Materials Drive HepG2 Spheroid Differentiation
Liu, T., van den Berk, L., Wondergem, J. A. J., Tong, C., Kwakernaak, M. C., ter Braak, B., Heinrich, D., van de Water, B., & Kieltyka, R. E. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001903 · Cited by 35 · see citing works
Tricot, T., Verfaillie, C. M., & Kumar, M. (2022) · Cells · doi:10.3390/cells11030442 · Cited by 35 · see citing works
Copple, I. M., den Hollander, W., Callegaro, G., Mutter, F., Maggs, J. L., Schofield, A. L., Rainbow, L., Fang, Y., Sutherland, J. J., Ellis, E. C. S., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2354-1 · Cited by 33 · see citing works
Self-citationLorvellec, M., Scottoni, F., Crowley, C., Fiadeiro, R., Maghsoudlou, P., Pellegata, A. F., Mazzacuva, F., Gjinovci, A., Lyne, A.-M., Zulini, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189586 · Cited by 30 · see citing works
Organoids as preclinical models of human disease: progress and applications
Chen, B., Du, C., Wang, M., Guo, J., & Liu, X. (2024) · Medical Review · doi:10.1515/mr-2023-0047 · Cited by 30 · see citing works
Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells
Zabulica, M., Jakobsson, T., Ravaioli, F., Vosough, M., Gramignoli, R., Ellis, E. C. S., Rooyackers, O., & Strom, S. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031217 · Cited by 28 · see citing works
Modelling urea cycle disorders using iPSCs
Duff, C. E., & Baruteau, J. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00252-5 · Cited by 23 · see citing works
Yanagihara, K., Liu, Y., Kanie, K., Takayama, K., Kokunugi, M., Hirata, M., Fukuda, T., Suga, M., Nikawa, H., Mizuguchi, H., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0099 · Cited by 25 · see citing works
Stem Cell-Derived Hepatocyte-Like Cells as Model for Viral Hepatitis Research
Wang, J., Qu, B., Zhang, F., et al. (2019) · Stem Cells International · doi:10.1155/2019/9605252 · Cited by 24 · see citing works
The Use of Human Pluripotent Stem Cells for Modeling Liver Development and Disease
Heslop, J. A., & Duncan, S. A. (2018) · Hepatology · doi:10.1002/hep.30288 · Cited by 23 · see citing works
Self-citationResearch and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project
Ishida, S. (2021) · Frontiers in Toxicology · doi:10.3389/ftox.2021.657765 · Cited by 25 · see citing works
Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
Viiri, L. E., Rantapero, T., Kiamehr, M., Alexanova, A., Oittinen, M., Viiri, K. M., Niskanen, H., Nykter, M., Kaikkonen, M. U., & Aalto‐Setälä, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39215-0 · Cited by 21 · see citing works
Ackerson, T. J., Amberg, A., Atzrodt, J., Arabeyre‐Fabre, C., Defoßa, E., Dorau, M., Dudda, A., Dwyer, J., Holla, W., Kissner, T., et al. (2019) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22345 · Cited by 24 · see citing works
Hoff, J. S., Xiong, L., Kammann, T., Neugebauer, S., Micheel, J., Ghait, M., Deshmukh, S. D., Gaßler, N., Bauer, M. W., & Press, A. T. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05794-0 · Cited by 22 · see citing works
Chen, Y., Tang, D., Wu, H., Wu, Y., Yuan, T., Zhang, H., Jiao, Y., Yu, W., & Yan, H. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03050-y · Cited by 20 · see citing works
Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture
Ellero, A. A., van den Bout, I., Vlok, M., Cromarty, D., & Hurrell, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89907-9 · Cited by 20 · see citing works
Alternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Tricot, T., De Boeck, J., & Verfaillie, C. (2020) · Cells · doi:10.3390/cells9030566 · Cited by 20 · see citing works
Hepatic organoids as a platform for liver disease modeling and the development of novel therapies
Luce, E., Messina, A., & Duclos‐Vallée, J. (2025) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2025.102647 · Cited by 20 · see citing works
Chan, C. Y. S., Roberts, O. L., Rajoli, R. K. R., Liptrott, N. J., Siccardi, M., Almond, L. M., & Owen, A. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.004 · Cited by 19 · see citing works
What gastroenterologists and hepatologists should know about organoids in 2019
Günther, C., Brevini, T., Sampaziotis, F., & Neurath, M. F. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.02.020 · Cited by 19 · see citing works
Orge, I. D., Gadd, V. L., Barouh, J. L., Rossi, E. A., Carvalho, R. H., Smith, I. P., Allahdadi, K. J., Paredes, B. D., Silva, D. N., Damasceno, P. K. F., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01665-z · Cited by 19 · see citing works
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?
Terryn, J., Tricot, T., Gajjar, M. K., & Verfaillie, C. M. (2018) · F1000Research · doi:10.12688/f1000research.12596.1 · Cited by 18 · see citing works
Microfabrication of liver and heart tissues for drug development
Brown, G. E., & Khetani, S. R. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0225 · Cited by 19 · see citing works
Liu, P. J., Harris, J. M., Marchi, E., D’Arienzo, V., Michler, T., Wing, P. A. C., Magrì, A., Ortega‐Prieto, A. M., van de Klundert, M. A. A., Wettengel, J. M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70865-7 · Cited by 19 · see citing works
Advancing hepatotoxicity assessment: current advances and future directions
Kim, Y., Kim, Y., & Kim, Y. (2025) · Toxicological Research · doi:10.1007/s43188-025-00289-w · Cited by 20 · see citing works
Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures
Suominen, S., Hyypijev, T., Venäläinen, M., Yrjänäinen, A., Vuorenpää, H., Lehti-Polojärvi, M., Räsänen, M., Seppänen, A., Hyttinen, J., Miettinen, S., et al. (2023) · Cells · doi:10.3390/cells12192368 · Cited by 20 · see citing works
Pelechá-Salvador, M., Villanueva-Bádenas, E., Timor-López, E., Donato, M. T., & Tolosa, L. (2021) · Antioxidants · doi:10.3390/antiox11010086 · Cited by 16 · see citing works
Sanchez-Quant, E., Richter, M. L., Colomé‐Tatché, M., & Martinez‐Jimenez, C. P. (2023) · Genome biology · doi:10.1186/s13059-023-03075-9 · Cited by 14 · see citing works
APOE genotype dictates lipidomic signatures in primary human hepatocytes
Almeida, F., Patra, K., Giannisis, A., Niesnerova, A., Nandakumar, R., Ellis, E. C. S., Oliveira, T. G., & Nielsen, H. M. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100498 · Cited by 14 · see citing works
Opportunities and challenges for hepatitis B cure
Suarez, A. A. R., & Zoulim, F. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100021 · Cited by 14 · see citing works
Wang, S., Chen, L., Wang, Q., He, Z., Chen, S., Zhang, H., Li, H., Guo, P., Li, Q., Zhang, R., et al. (2018) · Toxicology · doi:10.1016/j.tox.2018.11.011 · Cited by 14 · see citing works
Qiao, S., Feng, S., Wu, Z., He, T., Ma, C., Peng, Z., Tian, E., & Pan, G. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.120.000275 · Cited by 14 · see citing works
Romaldini, A., Spanò, R., Catalano, F., Villa, F., Poggi, A. L., & Sabella, S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.867728 · Cited by 13 · see citing works
Slc7a11 stimulates glutathione synthesis to preserve fatty acid metabolism in primary hepatocytes
Liu, Y., Wu, K., Fu, Y., Li, W., & Zhao, X.-Y. (2023) · Redox Report · doi:10.1080/13510002.2023.2260646 · Cited by 14 · see citing works
Burton, L., Scaife, P. J., Paine, S. W., Mellor, H. R., Abernethy, L., Littlewood, P., & Rauch, C. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00472.2019 · Cited by 13 · see citing works
Model-based translation of DNA damage signaling dynamics across cell types
Heldring, M. M., Wijaya, L. S., Niemeijer, M., Yang, H., Lakhal, T., Dévédec, S. E. L., van de Water, B., & Beltman, J. B. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010264 · Cited by 12 · see citing works
Ali, S.-E., Waddington, J. C., Lister, A., Sison-Young, R. L. C., Jones, R. P., Rehman, A. H., Goldring, C. E., Naisbitt, D. J., & Meng, X. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad015 · Cited by 11 · see citing works
Self-citationUeyama-Toba, Y., Tong, Y., Yokota, J., Murai, K., Hikita, H., Eguchi, H., Takehara, T., & Mizuguchi, H. (2024) · iScience · doi:10.1016/j.isci.2024.110778 · Cited by 11 · see citing works
Hepatocyte dedifferentiation in 2D culture reveals extensive transcriptomic and proteomic rewiring
Dall, M., Stocks, B., Cervone, D. T., Deshmukh, A. S., & Treebak, J. T. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000795 · Cited by 10 · see citing works
Analysis of culture and RNA isolation methods for precision-cut liver slices from cirrhotic rats
Leaker, B. D., Wang, Y., Tam, J., & Anderson, R. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-66235-2 · Cited by 11 · see citing works
Sa‐ngiamsuntorn, K., Thongsri, P., Pewkliang, Y., Wongkajornsilp, A., Kongsomboonchoke, P., Suthivanich, P., Borwornpinyo, S., & Hongeng, S. (2019) · Viruses · doi:10.3390/v11100952 · Cited by 9 · see citing works
Chen, N., Zhao, X., Wang, F., Lu, Z., Wang, Y., & Jin, M. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116147 · Cited by 9 · see citing works
Limitations of acetaminophen as a reference hepatotoxin for the evaluation of in vitro liver models
Livoti, L. A., Sison-Young, R. L. C., Reddyhoff, D., Fisher, C. P., Gardner, I. B., Díaz-Nieto, R., Goldring, C. E., & Copple, I. M. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae133 · Cited by 8 · see citing works
Self-citationIn vitro liver models for toxicological research
Fukunaga, I., & Takebe, T. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101478 · Cited by 7 · see citing works
Human embryoid bodies to hepatocyte-like clusters: Preparing for translation
Pettinato, G., Thompson, M. T., & Fisher, R. A. (2017) · Liver Research · doi:10.1016/j.livres.2017.08.004 · Cited by 7 · see citing works
Effect of supramolecular peptide hydrogel scaffold charge on HepG2 viability and spheroid formation
Xin, Y., Ligorio, C., O’Brien, M., Collins, R. F., Dong, S., Miller, A. F., Saiani, A., & Gough, J. E. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01701c · Cited by 7 · see citing works
van der Mark, V. A., Adam, A. A. A., Chang, J., Elferink, R. P. J. O., Chamuleau, R. A. F. M., & Hoekstra, R. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115055 · Cited by 7 · see citing works
Adam, A. A. A., Jongejan, A., Moerland, P. D., van der Mark, V. A., Elferink, R. P. J. O., Chamuleau, R. A. F. M., & Hoekstra, R. (2020) · Cytotechnology · doi:10.1007/s10616-020-00384-w · Cited by 6 · see citing works
Multicellular Liver Organoids: Generation and Importance of Diverse Specialized Cellular Components
Ietto, G., Iori, V., Gritti, M., Inversini, D., Costantino, A., Barba, S. I., Jiang, Z. G., Carcano, G., Gasperina, D. D., & Pettinato, G. (2023) · Cells · doi:10.3390/cells12101429 · Cited by 8 · see citing works
Status and Use of Induced Pluripotent Stem Cells (iPSCs) in Toxicity Testing
Wong, M. W., Pridgeon, C. S., Schlott, C., Park, B. K., & Goldring, C. E. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_10 · Cited by 6 · see citing works
Self-citationHelsen, N., Vervoort, T., Vandenbossche, J. J., Lenz, O., Monshouwer, M., Pauwels, F., & Snoeys, J. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-18 · Cited by 6 · see citing works
Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
Wu, W., Anas, F., Koc, B., Tian, L., Hasselkus, R., Rezania, D., Sharareh, S., Farberov, L., Zlotnik, D., Alon, A., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118021 · Cited by 5 · see citing works
Liu, X., Higuchi, Y., Sakamoto, Y., Yanagida, S., Uehara, S., Suemizu, H., Kanda, Y., & Kawagishi, H. (2025) · Journal of Applied Toxicology · doi:10.1002/jat.4863 · Cited by 5 · see citing works
Borgström, A., Filippi, B. G. H., Hewitt, P. G., Wolf, A., & Gebauer, M. (2023) · Applied In Vitro Toxicology · doi:10.1089/aivt.2023.0004 · Cited by 4 · see citing works
Biotransformation novel advances – 2021 year in review
Khojasteh, S. C., Argikar, U. A., Cho, S., Crouch, R. D., Heck, C. J. S., Johnson, K. M., Kalgutkar, A. S. S., King, L. M., Maw, H. H., Seneviratne, H. K., et al. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2097253 · Cited by 7 · see citing works
Winkler, R., & Lü, H. (2023) · Mediators of Inflammation · doi:10.1155/2023/4399998 · Cited by 5 · see citing works
Recapitulating the liver niche in vitro
Yap, K. K., & Mitchell, G. M. (2022) · Advances in stem cells and their niches · doi:10.1016/bs.asn.2021.10.002 · Cited by 3 · see citing works
Tricot, T., Thibaut, H. J., Abbasi, K., Boon, R., Helsen, N., Kumar, M., Neyts, J. H., & Verfaillie, C. M. (2022) · Biomedicines · doi:10.3390/biomedicines10020268 · Cited by 4 · see citing works
Vu, L. T., Orbach, S. M., Ray, W. K., Cassin, M. E., Rajagopalan, P., & Helm, R. F. (2016) · Proteome Science · doi:10.1186/s12953-017-0120-6 · Cited by 4 · see citing works
Vasoactive intestinal peptide induces proliferation of human hepatocytes
Khedr, M. E. M. S., Abdelmotelb, A., Bedwell, T. A., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12482 · Cited by 4 · see citing works
Sanchez-Quant, E., Richter, M. L., Colomé‐Tatché, M., & Martinez‐Jimenez, C. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495252 · Cited by 3 · see citing works
Meijer, T., ter Braak, B., Wolters, L., Kunnen, S. J., Islam, B., Suciu, I., Gardner, I. B., Hatley, O. J. D., Currie, R. A., Hardy, B. J., et al. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106010 · Cited by 3 · see citing works
Štaflová, K., Clarová, K., Doležal, M., et al. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002170 · Cited by 3 · see citing works
Vos, K. D., Mavrogiannis, A. V., Wolters, J. C., Schlenner, S., Wierda, K. D. B., Calabuig, Á. C., Chinnaraj, R., Dermesrobian, V., Armoudjian, Y., Jacquemyn, M., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116445 · Cited by 3 · see citing works
Engineering a three-dimensional liver steatosis model
Johnston, E. K., Zhou, F., Soto–Gutiérrez, A., Taner, C. B., Cook, K. E., Liu, Y., & Abbott, R. D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167888 · Cited by 3 · see citing works
Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance
Hurrell, T., Naidoo, J., & Scholefield, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.864725 · Cited by 3 · see citing works
Synthetic human livers for modeling metabolic diseases
Tafaleng, E. N., Malizio, M. R., Fox, I. J., & Soto–Gutiérrez, A. (2021) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000726 · Cited by 3 · see citing works
Li, Y., Sheng, H., Zhou, T., Xing, C., Kukasch, M., Shao, S., Youhanna, S. C., Vorrink, S. U., Liang, Y., Nies, A. T., et al. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100346 · Cited by 3 · see citing works
Brenner, D., Bergo, A. M., Řehůřková, E., Havlík, J., Babica, P., & Sovadinová, I. (2026) · Toxicology · doi:10.1016/j.tox.2026.154538 · Cited by 2 · see citing works
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2 · see citing works
Self-citationFrancis, L., Ogungbenro, K., Bruyn, T. D., et al. (2023) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001309 · Cited by 2 · see citing works
Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate
Pistoni, M., Helsen, N., Vanhove, J., Boon, R., Xu, Z., Ordovás, L., & Verfaillie, C. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186884 · Cited by 2 · see citing works
- Authors
- Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., Fenwick, S., Chadwick, A. E., Mills, J., Kitteringham, N. R., Goldring, C. E. P., & Kevin Park, B.
- Affiliations
- University of Liverpool (GB)
- University of Oxford (GB)
- Aintree University Hospital (GB)
- AstraZeneca (United Kingdom) (GB)
- ORCID
- Venue
- Archives of Toxicology
- Published
- 2016-04-02
- Volume
- 91
- Issue
- 1
- Pages
- 439-452
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC5225178
- OpenAlex
- W2321561488
- Semantic Scholar
- 738c624a59802860e61440bd9f6ab427176b529f
- Cited by
- 141
- References
- 46
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 10 · 2023: 15 · 2022: 16 · 2021: 12 · 2020: 17 · 2019: 10 · 2018: 18 · 2017: 7 · 2016: 6
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Archives of Toxicology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Biotechnology and Biological Sciences Research Council (GB) (BB/J500756/1)
- Medical Research Council (GB) (MR/L006758/1 and G0700654)
- European Parliament (BE) (115336)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- primary human hepatocytes, hepatocyte dedifferentiation, hepatocyte culture, proteomic profiling, cytochrome P450, mitochondrial proteome, drug metabolism, hepatotoxicity assessment, stem cell-derived hepatocytes
- MeSH terms
- Cells, Cultured, Humans, Kinetics, Mitochondria, Liver, Pharmacology, Rotenone, Toxicology, Uncoupling Agents, Reproducibility of Results, Gene Expression Regulation, Developmental, Proteome, Gene Expression Profiling, Hepatocytes, Electron Transport Complex I, Cell Dedifferentiation, Protein Stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-23.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-23.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review